Breaking the cycle: should we target inflammation, fibrosis, or both?
Left unchecked, many chronic inflammatory and autoimmune diseases lead to fibrosis, which can ultimately irreversibly compromise tissue and organ function. A key question for therapeutic discovery and development is whether it is preferable to target i…